AbbVie, Inc. ABBV
NYSE · United States · Health Technology
$261.59-1.70 (-0.65%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Zacks highlights Johnson & Johnson, Coca-Cola and AbbVie for years of dividend increases and says their shares have outperformed the S&P 500 in 2026.
Johnson & Johnson shares climbed despite slower revenue growth, as investors weigh new-drug momentum against Stelara losses and softer MedTech sales.
AbbVie offers faster-growing drug sales and a rising payout, while Pfizer’s much higher yield comes with a tougher recovery to prove.